Ribonexus

Paris, France

Ribonexus is a biotech specializing in the development of new therapies to combat cancer disease.

$1.5M raised

Apr 2022

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ribonexus raised?

Ribonexus has raised $1.5M in total funding. The most recent round was Debt Financing. The last funding was announced in April 2022.

Who are Ribonexus's investors?

Ribonexus's investors include Bpifrance, AdBio partners, Pierre Fabre, Crédit Mutuel Innovation.

Where is Ribonexus headquartered?

Ribonexus is headquartered in Paris, France.

What does Ribonexus do?

Ribonexus is a biotech specializing in the development of new therapies to combat cancer disease.

What stage is Ribonexus at?

Ribonexus is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 12, 2022.

MLA

"Ribonexus — Funding & Investors." VCBacked, April 12, 2022, https://www.vcbacked.co/company/ribonexus. Accessed July 1, 2026.

APA

VCBacked. (2022). Ribonexus — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/ribonexus

Wikipedia (cite web)

{{cite web |title=Ribonexus — Funding & Investors |url=https://www.vcbacked.co/company/ribonexus |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 12, 2022.